MENU

BOLT Bolt Biotherapeutics Inc Forecast, Technical & Fundamental Analysis

Bolt Biotherapeutics Inc is a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer... Show more

BOLT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
BOLT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

BOLT is expected to report earnings to fall 47.48% to -240 cents per share on November 11

Bolt Biotherapeutics Inc BOLT Stock Earnings Reports
Q3'26
Est.
$-2.40
Q2'26
Missed
by $1.24
Q1'26
Missed
by $3.95
Q4'25
Missed
by $3.54
Q3'25
Missed
by $3.42
The last earnings report on August 11 showed earnings per share of -457 cents, missing the estimate of -332 cents. With 9.26K shares outstanding, the current market capitalization sits at 7.86M.
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TCRT3.080.11
+3.70%
Alaunos Therapeutics Inc.
PLBY1.13N/A
N/A
Playboy Inc
DKL56.77-0.41
-0.72%
Delek Logistics Partners LP
LXRX1.56-0.02
-1.27%
Lexicon Pharmaceuticals
PHM112.89-1.64
-1.43%
Pultegroup

BOLT and Stocks

Correlation & Price change

A.I.dvisor tells us that BOLT and XENE have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BOLT and XENE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BOLT
1D Price
Change %
BOLT100%
-1.90%
XENE - BOLT
31%
Poorly correlated
-0.88%
ARRY - BOLT
30%
Poorly correlated
+2.40%
NRXP - BOLT
29%
Poorly correlated
+0.38%
KRRO - BOLT
29%
Poorly correlated
-1.59%
SPRO - BOLT
28%
Poorly correlated
-4.10%
More
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Industry
N/A
Address
900 Chesapeake Drive
Phone
+1 650 665-9295
Employees
23
Web
https://www.boltbio.com
Bolt Biotherapeutics (BOLT) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com